{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:25:16Z","timestamp":1787163916377,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12888-019-2107-6","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T01:38:13Z","timestamp":1556069893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["First known case of catatonia due to cyclosporine A-related neurotoxicity in a pediatric patient with steroid-resistant nephrotic syndrome"],"prefix":"10.1186","volume":"19","author":[{"given":"R. David","family":"Heekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalonda","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadi A.","family":"Calarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"2107_CR1","unstructured":"Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013. p. 119\u2013121."},{"key":"2107_CR2","first-page":"121","volume-title":"Catatonia: from psychopathology to neurobiology","author":"B Carroll","year":"2004","unstructured":"Carroll B, Goforth H. Medical catatonia. In: Caroff S, Mann S, Francis A, Fricchione G, editors. Catatonia: from psychopathology to neurobiology. Washington, DC: American Psychiatric Publishing; 2004. p. 121\u20137."},{"key":"2107_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(76)92669-6","volume":"1","author":"AJ Gelenberg","year":"1976","unstructured":"Gelenberg AJ. The catatonic syndrome. Lancet. 1976;1:1339\u201341.","journal-title":"Lancet"},{"key":"2107_CR4","first-page":"327","volume":"42","author":"N Ahuja","year":"2000","unstructured":"Ahuja N. Organic catatonia: a review. Indian J Psychiatry. 2000;42:327\u201346.","journal-title":"Indian J Psychiatry"},{"key":"2107_CR5","unstructured":"Denysenko L, Freudenreich O, Philbrick K, Penders T, Zimbrean P, Nejad S, et al. Catatonia in medically ill patients: an evidence-based medicine (EBM) monograph for psychosomatic medicine practice. The guidelines and evidence-based medicine Subcommittee of the Academy of psychosomatic medicine (APM) and the European Association of Psychosomatic Medicine (EAPM). 2015. https:\/\/www.eapm.eu.com\/wp-content\/uploads\/2018\/06\/Catatonia_APM-EAPM_2015-04-17.pdf . Accessed 27 May 2018."},{"key":"2107_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.schres.2009.04.021","volume":"113","author":"F Cornic","year":"2009","unstructured":"Cornic F, Consoli A, Tanguy M, Bonnot O, P\u00e9risse D, Tordjman S, Laurent C, Cohen D. Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res. 2009;113:233\u201340.","journal-title":"Schizophr Res"},{"key":"2107_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s004150050360","volume":"246","author":"J Gijtenbeek","year":"1999","unstructured":"Gijtenbeek J, van den Bent M, Vecht C. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246:339\u201346.","journal-title":"J Neurol"},{"key":"2107_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.120975","volume":"4","author":"E Russo","year":"2013","unstructured":"Russo E, Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013;4:94.","journal-title":"J Pharmacol Pharmacother"},{"key":"2107_CR9","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00508-017-1221-z","volume":"129","author":"D Batini\u0107","year":"2017","unstructured":"Batini\u0107 D, Milo\u0161evi\u0107 D, Filipovi\u0107-Gr\u010di\u0107 B, Topalovi\u0107-Grkovi\u0107 M, Bari\u0161i\u0107 N, Turudi\u0107 D. Neurotoxicity of cyclosporine a in children with steroid-resistant nephrotic syndrome: is cytotoxic edema really an unfavorable predictor of permanent neurological damage? Wien Klin Wochenschr. 2017;129:579\u201382.","journal-title":"Wien Klin Wochenschr"},{"key":"2107_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00467-003-1347-2","volume":"19","author":"S Taque","year":"2004","unstructured":"Taque S, Peudenier S, Gie S, Rambeau M, Gandemer V, Bridoux L, B\u00e9tr\u00e9mieux P, De Parscau L, Le Gall E. Central neurotoxicity of cyclosporine in two children with nephrotic syndrome. Pediatr Nephrol. 2004;19:276\u201380.","journal-title":"Pediatr Nephrol"},{"key":"2107_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/nep.12518","volume":"20","author":"J Zhou","year":"2015","unstructured":"Zhou J, Zheng H, Zhong X, Wu D, Wang M, Tang X, Li Q. Reversible posterior encephalopathy syndrome in children with nephrotic syndrome. Nephrology. 2015;20:849\u201354.","journal-title":"Nephrology."},{"key":"2107_CR12","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1093\/ndt\/gfn013","volume":"23","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant. 2008;23:2531\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"2107_CR13","first-page":"369","volume":"53","author":"J Kwinta-Rybicka","year":"1996","unstructured":"Kwinta-Rybicka J, Ogarek I, Sancewicz-Pach K. Neurotoxicity of cyclosporine a in therapy of steroid resistant nephrotic syndrome in a 10-year old boy. Przegl Lek. 1996;53:369\u201370.","journal-title":"Przegl Lek"},{"key":"2107_CR14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/j.1875-9114.1996.tb03639.x","volume":"16","author":"M Hauben","year":"1996","unstructured":"Hauben M. Cyclosporine neurotoxicity. Pharmacotherapy. 1996;16:576\u201383.","journal-title":"Pharmacotherapy."},{"key":"2107_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0033-3182(93)71938-6","volume":"34","author":"L Bernstein","year":"1993","unstructured":"Bernstein L, Levin R. Catatonia responsive to intravenous lorazepam in a patient with cyclosporine neurotoxicity and hypomagnesemia. Psychosomatics. 1993;34:102\u20133.","journal-title":"Psychosomatics."},{"key":"2107_CR16","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/jnnp.53.12.1068","volume":"53","author":"G Bird","year":"1990","unstructured":"Bird G, Meadows J, Goka J, Polson R, Williams R. Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry. 1990;53:1068\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2107_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2169\/internalmedicine.42.750","volume":"42","author":"M Nishie","year":"2003","unstructured":"Nishie M, Kurahashi K, Ogawa M, Yoshida Y, Midorikawa H. Posterior encephalopathy subsequent to cyclosporin a presenting as irreversible abulia. Intern Med. 2003;42:750\u20135.","journal-title":"Intern Med"},{"key":"2107_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman A, Hughes E, Rossi J, Peng X, Lai M, Dessain S, Rosenfeld M, Balice-Gordon R, Lynch D. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol."},{"key":"2107_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/archgenpsychiatry.2009.141","volume":"66","author":"M Fink","year":"2009","unstructured":"Fink M, Taylor M. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009;66:1173.","journal-title":"Arch Gen Psychiatry"},{"key":"2107_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"J Dalmau","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63\u201374.","journal-title":"Lancet Neurol"},{"key":"2107_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer M, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman A, Balice-Gordon R, Rosenfeld M, Lynch D, Graus F, Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA-receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167\u201377.","journal-title":"Lancet Neurol."},{"key":"2107_CR22","unstructured":"F06.1 Organic catatonic disorder. In: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization. 1992.\u00a0 https:\/\/www.who.int\/classifications\/icd\/en\/bluebook.pdf . Accessed 1 Feb 2019."},{"key":"2107_CR23","doi-asserted-by":"publisher","unstructured":"Schizophrenia Spectrum and Other Psychotic Disorders. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.\u00a0 https:\/\/doi.org\/10.1176\/appi.books.9780890425596.dsm02 . Accessed 1 Feb 2019.","DOI":"10.1176\/appi.books.9780890425596.dsm02"},{"key":"2107_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.psym.2012.03.003","volume":"54","author":"E Alfson","year":"2013","unstructured":"Alfson E, Awosika O, Singhal T, Fricchione G. Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. Psychosomatics. 2013;54:192\u20135.","journal-title":"Psychosomatics."},{"key":"2107_CR25","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1213\/ANE.0b013e3182501b04","volume":"115","author":"MC Smith","year":"2012","unstructured":"Smith MC, Williamson J, Yaster M, Boyd GJ, Heitmiller ES. Off-label use of medications in children undergoing sedation and anesthesia. Anesth Analg. 2012;115:1148\u201354.","journal-title":"Anesth Analg"},{"key":"2107_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.pec.0000101578.65509.71","volume":"19","author":"DS Wheeler","year":"2003","unstructured":"Wheeler DS, Vaux KK, Ponaman ML, Poss BW. The safe and effective use of propofol sedation in children undergoing diagnostic and therapeutic procedures: experience in a pediatric ICU and a review of the literature. Pediatr Emerg Care. 2003;19:385\u201392.","journal-title":"Pediatr Emerg Care"},{"key":"2107_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0929867003375335","volume":"7","author":"G Trapani","year":"2000","unstructured":"Trapani G, Altomare C, Sanna E, Biggio G, Liso G. Propofol in anesthesia: mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem. 2000;7:249\u201371.","journal-title":"Curr Med Chem"},{"key":"2107_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1527-3458.2008.00043.x","volume":"14","author":"Y Kotani","year":"2008","unstructured":"Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther. 2008;14:95\u2013106.","journal-title":"CNS Neurosci Ther"},{"key":"2107_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acps.12038","volume":"127","author":"M Fink","year":"2012","unstructured":"Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand. 2012;127:1\u201347.","journal-title":"Acta Psychiatr Scand"},{"key":"2107_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083964","volume":"38","author":"F Heijden Van der","year":"2005","unstructured":"Van der Heijden F, Tuinier S, Arts N, Hoogendoorn M, Kahn R, Verhoeven W. Catatonia: disappeared or under-diagnosed? Psychopathology. 2005;38:3\u20138.","journal-title":"Psychopathology."},{"key":"2107_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1600-0447.2011.01778.x","volume":"125","author":"N Ghaziuddin","year":"2011","unstructured":"Ghaziuddin N, Dhossche D, Marcotte K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2011;125:33\u20138.","journal-title":"Acta Psychiatr Scand"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/026988110101500412","volume":"15","author":"EM Cassidy","year":"2001","unstructured":"Cassidy EM, O'Brien M, Osman MF, Finucane J, O'Keane V. Lethal catatonia responding to high-dose olanzapine therapy. J Psychopharmacol. 2001;15:302\u20134.","journal-title":"J Psychopharmacol"},{"key":"2107_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1440-1614.2006.01828.x","volume":"40","author":"R Nicolato","year":"2006","unstructured":"Nicolato R, Romano-Silva MA, Correa H, dos Santos RR, Teixeira AL. Stuporous catatonia in an elderly bipolar patient: response to olanzapine. Aust N Z J Psychiatry. 2006;40:498.","journal-title":"Aust N Z J Psychiatry"},{"key":"2107_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/01.WNF.0000220816.86478.84","volume":"29","author":"QR Tan","year":"2006","unstructured":"Tan QR, Wang W, Wang HH, Zhang RG, Guo L, Zhang YH. Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report. Clin Neuropharmacol. 2006;29:154\u20136.","journal-title":"Clin Neuropharmacol"},{"key":"2107_CR35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1176\/appi.psy.48.6.534","volume":"48","author":"PW Babington","year":"2007","unstructured":"Babington PW, Spiegel DR. Treatment of catatonia with olanzapine and amantadine. Psychosomatics. 2007;48:534\u20136.","journal-title":"Psychosomatics."},{"key":"2107_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1440-1819.2008.01819.x","volume":"62","author":"CS Guzman","year":"2008","unstructured":"Guzman CS, Myung VH, Wang YP. Treatment of periodic catatonia with atypical antipsychotic, olanzapine. Psychiatry Clin Neurosci. 2008;62:482.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2107_CR37","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.pnpbp.2009.08.018","volume":"33","author":"CH Chang","year":"2009","unstructured":"Chang CH, Hsiao YL, Hsu CY, Chen ST. Treatment of catatonia with olanzapine: a case report. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:1559\u201360.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"2107_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5692\/clinicalneurol.50.329","volume":"50","author":"Hayato Suzuki","year":"2010","unstructured":"Suzuki H, Fukushima T, Makino K, Kuwabara T. [Patient with encephalitis presenting with olanzapine-responsive malignant catatonia]. Rinsho Shinkeigaku. 2010;50:329\u2013331. Japanese.","journal-title":"Rinsho Shinkeigaku"},{"key":"2107_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/cap.2009.0046","volume":"20","author":"MF Ceylan","year":"2010","unstructured":"Ceylan MF, Kul M, Kultur SE, Kilincaslan A. Major depression with catatonic features in a child remitted with olanzapine. J Child Adolesc Psychopharmacol. 2010;20:225\u20137.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2107_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1192\/bjp.bp.108.054072","volume":"197","author":"S Jauhar","year":"2010","unstructured":"Jauhar S, Blackett A, Srireddy P, McKenna PJ. Pernicious anaemia presenting as catatonia without signs of anaemia or macrocytosis. Br J Psychiatry. 2010;197:244\u20135.","journal-title":"Br J Psychiatry"},{"key":"2107_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1819.2012.02368.x","volume":"66","author":"S Ueda","year":"2012","unstructured":"Ueda S, Takeuchi J, Okubo Y. Successful use of olanzapine for catatonia following delirium. Psychiatry Clin Neurosci. 2012;66:465.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2107_CR42","doi-asserted-by":"publisher","first-page":"360.e3","DOI":"10.1016\/j.genhosppsych.2014.01.001","volume":"36","author":"M Kusztal","year":"2014","unstructured":"Kusztal M, Piotrowski P, Mazanowska O, Misiak B, Kantorska-Janiec M, Boraty\u0144ska M, Klinger M, Kiejna A. Catatonic episode after kidney transplantation. Gen Hosp Psychiatry. 2014;36:360.e3\u20135.","journal-title":"Gen Hosp Psychiatry"},{"key":"2107_CR43","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.2147\/NDT.S52311","volume":"9","author":"B Yoshimura","year":"2013","unstructured":"Yoshimura B, Hirota T, Takaki M, Kishi Y. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat. 2013;9:1565\u201371.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2107_CR44","unstructured":"Sachs M, Madaan V. Electroconvulsive therapy in children and adolescents: brief overview and ethical issues. Am Acad Child Adolescent Psychiatry Ethics Committee. 2012; http:\/\/www.aacap.org\/app_themes\/aacap\/docs\/member_resources\/ethics\/in_workplace\/sachs_maadan_electroconvulsive_therapy_in_children_and_adolescents.pdf . Accessed 1 February 2019."},{"key":"2107_CR45","volume-title":"Catatonia: a clinician's guide to diagnosis and treatment","author":"M Fink","year":"2002","unstructured":"Fink M, Taylor M. Catatonia: a clinician's guide to diagnosis and treatment. Cambridge: Cambridge University Press; 2002."},{"key":"2107_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1176\/ajp.154.5.595","volume":"154","author":"J Rey","year":"1997","unstructured":"Rey J, Walter G. Half a century of ECT use in young people. Am J Psychiatr. 1997;154:595\u2013602.","journal-title":"Am J Psychiatr"},{"key":"2107_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5498\/wjp.v5.i2.182","volume":"5","author":"F Luchini","year":"2015","unstructured":"Luchini F, Medda P, Mariani M, Mauri M, Toni C, Perugi G. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatry. 2015;5:182.","journal-title":"World J Psychiatry"},{"key":"2107_CR48","first-page":"125","volume":"13","author":"R Abrams","year":"1997","unstructured":"Abrams R. The mortality rate with ECT. Convuls Ther. 1997;13:125\u20137.","journal-title":"Convuls Ther"},{"key":"2107_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.mehy.2010.11.001","volume":"76","author":"L Wachtel","year":"2011","unstructured":"Wachtel L, Dhossche D, Kellner C. When is electroconvulsive therapy appropriate for children and adolescents? Med Hypotheses. 2011;76:395\u20139.","journal-title":"Med Hypotheses"},{"key":"2107_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1176\/ajp.145.9.1181-c","volume":"145","author":"C Coffey","year":"1988","unstructured":"Coffey C, Figiel G, Djang W, Sullivan D, Herfkens R, Weiner R. Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. Am J Psychiatr. 1988;145:701\u20136.","journal-title":"Am J Psychiatr"},{"key":"2107_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/YCT.0b013e31804bb99d","volume":"23","author":"J Scalia","year":"2007","unstructured":"Scalia J, Lisanby S, Dwork A, Johnson J, Bernhardt E, Arango V, McCall W. Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression. J ECT. 2007;23:96\u20138.","journal-title":"J ECT"},{"key":"2107_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1192\/bjp.165.1.120","volume":"165","author":"A Hay","year":"1994","unstructured":"Hay A, Scott A. Electroconvulsive therapy and brain damage. Br J Psychiatry. 1994;165:120\u20131.","journal-title":"Br J Psychiatry"},{"key":"2107_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/YCT.0b013e3181937f3d","volume":"25","author":"G Kirov","year":"2009","unstructured":"Kirov G, Creaby M, Khalid N, Atkins M. Four years of successful maintenance electroconvulsive therapy. J ECT. 2009;25:219\u201320.","journal-title":"J ECT."},{"key":"2107_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/01.yct.0000176018.63613.d0","volume":"21","author":"J Wijkstra","year":"2005","unstructured":"Wijkstra J, Nolen W. Successful maintenance electroconvulsive therapy for more than seven years. J ECT. 2005;21:171\u20133.","journal-title":"J ECT."},{"key":"2107_CR55","doi-asserted-by":"crossref","unstructured":"Gryglewski G, Baldinger-Melich P, Seiger R, Godbersen GM, Michenthaler P, Kl\u00f6bl M, et al. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis. Br J Psychiatry. 2018:1\u20139.","DOI":"10.1192\/bjp.2018.224"},{"key":"2107_CR56","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1176\/appi.ajp.157.3.460","volume":"157","author":"D Cohen","year":"2000","unstructured":"Cohen D. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatr. 2000;157:460\u20132.","journal-title":"Am J Psychiatr"},{"key":"2107_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0924-9338(02)00668-5","volume":"17","author":"O Taieb","year":"2002","unstructured":"Taieb O, Flament M, Chevret S, Jeammet P, Allilaire J, Mazet P, Cohen D. Clinical relevance of electroconvulsive therapy (ECT) in adolescents with severe mood disorder: evidence from a follow-up study. Eur Psychiatry. 2002;17:206\u201312.","journal-title":"Eur Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-019-2107-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-019-2107-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T02:21:08Z","timestamp":1721182868000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-019-2107-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1186\/s12888-019-2107-6","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"assertion":[{"value":"1 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval to report this case was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report was obtained from the patient\u2019s parents. A copy of the signed written consent to publish is available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"123"}}